Shares ofEdwards Lifesciences Corporation(NYSE:EW) fell sharply during Thursday's session after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.

Edwards Lifesciences reported quarterly earnings of 70 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.632 billion which missed the analyst consensus estimate of $1.653 billion.

Edwards Lifesciences shares dipped 26.9% to $63.60 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Predictive Oncology Inc. (NASDAQ:POAI) shares jumped 85% to...